Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Personalized Neoantigen Cancer Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06751849
What this trial is testing

Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

Who this might be right for
Advanced NSCLC
The First Affiliated Hospital of Nanchang University 10
Very early researchEnrolling By InvitationNCT07316361
What this trial is testing

GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer

Who this might be right for
Endometrial CarcinomaEndometrial Carcinoma Stage III
Biogenea Pharmaceuticals Ltd. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06751901
What this trial is testing

Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

Who this might be right for
Advanced NSCLC
The First Affiliated Hospital of Nanchang University 10
Not applicableUnknownNCT04145232
What this trial is testing

AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.

Who this might be right for
Non Small Cell Lung CancerNeoepitopesNeoantigens+3 more
Ardigen 30
Testing effectiveness (Phase 2)Study completedNCT03953235
What this trial is testing

A Personalized Cancer Vaccine Targeting Shared Neoantigens

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerPancreatic Cancer+2 more
Gritstone bio, Inc. 39
Very early researchLooking for participantsNCT06435351
What this trial is testing

Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

Who this might be right for
Breast CancerTriple Negative Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 16
Not applicableUnknownNCT05359354
What this trial is testing

Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Solid Tumors

Who this might be right for
Solid Tumor
YueJuan Cheng 36
Early research (Phase 1)Ended earlyNCT03422094
What this trial is testing

Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Who this might be right for
Glioblastoma
Washington University School of Medicine 3
Early research (Phase 1)Active Not RecruitingNCT05307835
What this trial is testing

Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection

Who this might be right for
Resectable Esophageal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 27
Early research (Phase 1)UnknownNCT05767684
What this trial is testing

Neoantigen Derived DCs as Cancer Treatment

Who this might be right for
Refractory TumorSolid Tumor
National Health Research Institutes, Taiwan 12
Testing effectiveness (Phase 2)UnknownNCT04998474
What this trial is testing

FRAME-001 Personalized Vaccine in NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Frame Pharmaceuticals B.V. 15
Early research (Phase 1)Looking for participantsNCT03219450
What this trial is testing

A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.

Who this might be right for
Lymphocytic Leukemia
Dana-Farber Cancer Institute 15
Early research (Phase 1)UnknownNCT04072900
What this trial is testing

A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma

Who this might be right for
Melanoma (Skin)
Xiangya Hospital of Central South University 30
Very early researchLooking for participantsNCT07328087
What this trial is testing

COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticColorectal Cancer Stage IIIColorectal Cancer Stage IV
Biogenea Pharmaceuticals Ltd. 12
Early research (Phase 1)Not Yet RecruitingNCT07686744
What this trial is testing

Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaAdvancedRecurrent+1 more
Jian Lin 8
Very early researchUnknownNCT05475106
What this trial is testing

Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms

Who this might be right for
Neoplasms
Instituto de Medicina Regenerativa 100
Not applicableLooking for participantsNCT06751940
What this trial is testing

Neoantigen-loaded DC Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment

Who this might be right for
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University 10
Testing effectiveness (Phase 2)Looking for participantsNCT07002203
What this trial is testing

Personalized Neoantigen Peptide Vaccines for Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRecurrent Cancer+2 more
Seqker Biosciences, Inc. 10
Early research (Phase 1)Active Not RecruitingNCT02287428
What this trial is testing

Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

Who this might be right for
Glioblastoma
Dana-Farber Cancer Institute 56
Very early researchNot Yet RecruitingNCT06156267
What this trial is testing

Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino

Who this might be right for
Pancreatic Cancer
Fudan University 30
Next Page